CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Boehringer Ingelheim Pharma against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Human Anti-Il-23 Antibodies, Compositions, Method And UsesJANSSEN BIOTECHMar 17, 2021
Improved Process For The Culturing Of CellsDPXJun 5, 2018
Improved Process For The Culturing Of CellsDPXJan 4, 2018
Improved Process For The Culturing Of CellsDPXJan 4, 2018

Explore Boehringer Ingelheim Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jul 27, 2022Use Of Dpp Iv Inhibitors5
Dec 11, 2019Atomizer, And Filter2
Aug 7, 2019Inhaler And Sieve For An Inhaler1
Feb 14, 2018Aerosol Formulation For The Inhalation Of Beta Agonists1
Nov 7, 2012Indolidone Derivatives For The Treatment Or Prevention Of Fibrotic Diseases1

Top competitors of Boehringer Ingelheim Pharma

Top competitors of Boehringer Ingelheim Pharma based on patent oppositions.